Baudax Common Stock Shares Outstanding vs Accounts Payable Analysis

BXRX Stock

USD 0.01 0.0006 5.66%

Baudax BioInc financial indicator trend analysis is way more than just evaluating Baudax BioInc prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Baudax BioInc is a good investment. Please check the relationship between Baudax BioInc Common Stock Shares Outstanding and its Accounts Payable accounts. Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.

Common Stock Shares Outstanding vs Accounts Payable

Common Stock Shares Outstanding vs Accounts Payable Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Baudax BioInc Common Stock Shares Outstanding account and Accounts Payable. At this time, the significance of the direction appears to have significant contrarian relationship.

The correlation between Baudax BioInc's Common Stock Shares Outstanding and Accounts Payable is -0.35. Overlapping area represents the amount of variation of Common Stock Shares Outstanding that can explain the historical movement of Accounts Payable in the same time period over historical financial statements of Baudax BioInc, assuming nothing else is changed. The correlation between historical values of Baudax BioInc's Common Stock Shares Outstanding and Accounts Payable is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Common Stock Shares Outstanding of Baudax BioInc are associated (or correlated) with its Accounts Payable. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Accounts Payable has no effect on the direction of Common Stock Shares Outstanding i.e., Baudax BioInc's Common Stock Shares Outstanding and Accounts Payable go up and down completely randomly.

Correlation Coefficient

-0.35

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Common Stock Shares Outstanding

The total number of shares of a company's common stock that are currently owned by all its shareholders.

Accounts Payable

An accounting item on the balance sheet that represents Baudax BioInc obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Baudax BioInc are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Most indicators from Baudax BioInc's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Baudax BioInc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.

Selling General Administrative is likely to rise to about 22.7 M in 2024, whereas Issuance Of Capital Stock is likely to drop slightly above 9.1 M in 2024.

	2021	2022	2023	2024 (projected)
Reconciled Depreciation	2.8M	2.2M	2.3M	1.7M
Total Operating Expenses	51.0M	30.0M	36.3M	38.0M

Reconciled Depreciation Total Operating Expenses

Baudax BioInc fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Accounts Payable	Non Current Assets Total	Non Currrent Assets Other	Good Will	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Non Current Liabilities Other	Net Working Capital	Intangible Assets	Common Stock	Property Plant Equipment	Short Long Term Debt Total	Current Deferred Revenue	Net Debt
Total Assets		-0.06	-0.14	0.27	0.57	-0.02	0.91	-0.19	0.79	0.17	0.57	-0.75	0.65	0.82	-0.26	0.33	0.89	0.7	0.57	0.47	0.44	0.03	0.89	-0.02	-0.3	-0.7
Other Current Liab	-0.06		0.99	-0.85	0.42	-0.88	-0.41	0.95	0.49	0.71	0.39	-0.55	0.36	0.48	-0.84	0.78	-0.41	-0.66	0.42	-0.9	0.71	-0.92	-0.41	-0.75	-0.73	-0.59
Total Current Liabilities	-0.14	0.99		-0.83	0.33	-0.84	-0.5	0.98	0.39	0.64	0.37	-0.46	0.26	0.4	-0.77	0.7	-0.5	-0.68	0.32	-0.92	0.64	-0.88	-0.5	-0.69	-0.64	-0.5
Total Stockholder Equity	0.27	-0.85	-0.83		-0.55	0.95	0.48	-0.8	-0.33	-0.77	-0.24	0.35	-0.47	-0.33	0.82	-0.8	0.54	0.8	-0.55	0.89	-0.69	0.93	0.47	0.82	0.75	0.5
Other Liab	0.57	0.42	0.33	-0.55		-0.73	0.46	0.24	0.85	0.79	0.61	-0.81	0.99	0.85	-0.82	0.86	0.37	-0.06	1.0	-0.18	0.89	-0.63	0.46	-0.69	-0.84	-0.91
Net Tangible Assets	-0.02	-0.88	-0.84	0.95	-0.73		0.23	-0.77	-0.59	-0.88	-0.43	0.61	-0.66	-0.58	0.95	-0.92	0.28	0.65	-0.73	0.8	-0.86	0.97	0.22	0.89	0.88	0.72
Property Plant And Equipment Net	0.91	-0.41	-0.5	0.48	0.46	0.23		-0.56	0.58	0.0	0.4	-0.52	0.54	0.57	-0.01	0.07	0.98	0.79	0.46	0.72	0.2	0.28	1.0	0.15	-0.08	-0.44
Accounts Payable	-0.19	0.95	0.98	-0.8	0.24	-0.77	-0.56		0.28	0.52	0.33	-0.35	0.19	0.34	-0.68	0.63	-0.57	-0.63	0.24	-0.89	0.55	-0.8	-0.57	-0.57	-0.54	-0.44
Non Current Assets Total	0.79	0.49	0.39	-0.33	0.85	-0.59	0.58	0.28		0.71	0.74	-0.99	0.86	0.95	-0.79	0.76	0.57	0.11	0.85	-0.13	0.86	-0.57	0.59	-0.6	-0.77	-0.95
Non Currrent Assets Other	0.17	0.71	0.64	-0.77	0.79	-0.88	0.0	0.52	0.71		0.52	-0.7	0.72	0.59	-0.95	0.83	-0.05	-0.54	0.79	-0.61	0.92	-0.84	0.04	-0.99	-0.94	-0.75
Good Will	0.57	0.39	0.37	-0.24	0.61	-0.43	0.4	0.33	0.74	0.52		-0.79	0.62	0.72	-0.63	0.46	0.38	0.04	0.61	-0.13	0.71	-0.45	0.41	-0.45	-0.48	-0.7
Common Stock Shares Outstanding	-0.75	-0.55	-0.46	0.35	-0.81	0.61	-0.52	-0.35	-0.99	-0.7	-0.79		-0.82	-0.94	0.8	-0.75	-0.52	-0.06	-0.81	0.19	-0.86	0.61	-0.54	0.61	0.75	0.94
Non Current Liabilities Total	0.65	0.36	0.26	-0.47	0.99	-0.66	0.54	0.19	0.86	0.72	0.62	-0.82		0.88	-0.77	0.83	0.45	0.05	0.99	-0.09	0.86	-0.56	0.54	-0.61	-0.79	-0.92
Other Current Assets	0.82	0.48	0.4	-0.33	0.85	-0.58	0.57	0.34	0.95	0.59	0.72	-0.94	0.88		-0.73	0.79	0.53	0.22	0.85	-0.09	0.82	-0.52	0.56	-0.47	-0.72	-0.97
Other Stockholder Equity	-0.26	-0.84	-0.77	0.82	-0.82	0.95	-0.01	-0.68	-0.79	-0.95	-0.63	0.8	-0.77	-0.73		-0.93	0.03	0.49	-0.82	0.67	-0.96	0.93	-0.03	0.92	0.94	0.85
Total Liab	0.33	0.78	0.7	-0.8	0.86	-0.92	0.07	0.63	0.76	0.83	0.46	-0.75	0.83	0.79	-0.93		0.01	-0.35	0.86	-0.56	0.91	-0.86	0.07	-0.79	-0.94	-0.88
Property Plant And Equipment Gross	0.89	-0.41	-0.5	0.54	0.37	0.28	0.98	-0.57	0.57	-0.05	0.38	-0.52	0.45	0.53	0.03	0.01		0.78	0.37	0.72	0.14	0.3	0.99	0.19	-0.02	-0.39
Total Current Assets	0.7	-0.66	-0.68	0.8	-0.06	0.65	0.79	-0.63	0.11	-0.54	0.04	-0.06	0.05	0.22	0.49	-0.35	0.78		-0.06	0.9	-0.29	0.71	0.75	0.66	0.39	-0.03
Non Current Liabilities Other	0.57	0.42	0.32	-0.55	1.0	-0.73	0.46	0.24	0.85	0.79	0.61	-0.81	0.99	0.85	-0.82	0.86	0.37	-0.06		-0.18	0.89	-0.63	0.46	-0.69	-0.84	-0.91
Net Working Capital	0.47	-0.9	-0.92	0.89	-0.18	0.8	0.72	-0.89	-0.13	-0.61	-0.13	0.19	-0.09	-0.09	0.67	-0.56	0.72	0.9	-0.18		-0.48	0.85	0.71	0.7	0.54	0.25
Intangible Assets	0.44	0.71	0.64	-0.69	0.89	-0.86	0.2	0.55	0.86	0.92	0.71	-0.86	0.86	0.82	-0.96	0.91	0.14	-0.29	0.89	-0.48		-0.8	0.21	-0.87	-0.95	-0.92
Common Stock	0.03	-0.92	-0.88	0.93	-0.63	0.97	0.28	-0.8	-0.57	-0.84	-0.45	0.61	-0.56	-0.52	0.93	-0.86	0.3	0.71	-0.63	0.85	-0.8		0.27	0.86	0.81	0.65
Property Plant Equipment	0.89	-0.41	-0.5	0.47	0.46	0.22	1.0	-0.57	0.59	0.04	0.41	-0.54	0.54	0.56	-0.03	0.07	0.99	0.75	0.46	0.71	0.21	0.27		0.11	-0.1	-0.44
Short Long Term Debt Total	-0.02	-0.75	-0.69	0.82	-0.69	0.89	0.15	-0.57	-0.6	-0.99	-0.45	0.61	-0.61	-0.47	0.92	-0.79	0.19	0.66	-0.69	0.7	-0.87	0.86	0.11		0.91	0.65
Current Deferred Revenue	-0.3	-0.73	-0.64	0.75	-0.84	0.88	-0.08	-0.54	-0.77	-0.94	-0.48	0.75	-0.79	-0.72	0.94	-0.94	-0.02	0.39	-0.84	0.54	-0.95	0.81	-0.1	0.91		0.85
Net Debt	-0.7	-0.59	-0.5	0.5	-0.91	0.72	-0.44	-0.44	-0.95	-0.75	-0.7	0.94	-0.92	-0.97	0.85	-0.88	-0.39	-0.03	-0.91	0.25	-0.92	0.65	-0.44	0.65	0.85

Click cells to compare fundamentals

Baudax BioInc Account Relationship Matchups

Baudax BioInc fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	54.2M	68.7M	53.3M	10.0M	9.0M	8.6M
Other Current Liab	7.1M	13.5M	12.0M	11.9M	10.7M	13.6M
Total Current Liabilities	7.7M	18.1M	15.6M	21.5M	19.3M	17.4M
Total Stockholder Equity	(16.7M)	(14.8M)	13.2M	(24.2M)	(27.9M)	(29.3M)
Other Liab	62.8M	56.6M	18.1M	10.7M	9.6M	9.1M
Net Tangible Assets	(45.2M)	(41.2M)	(10.6M)	(26.4M)	(30.3M)	(31.8M)
Property Plant And Equipment Net	5.6M	5.6M	5.0M	704K	633.6K	601.9K
Accounts Payable	271K	3.7M	1.5M	3.9M	3.5M	2.6M
Non Current Assets Total	34.1M	32.0M	29.8M	3.7M	3.3M	3.2M
Non Currrent Assets Other	34.1M	583K	963K	854K	768.6K	730.2K
Liabilities And Stockholders Equity	54.2M	68.7M	53.3M	10.0M	9.0M	8.6M
Non Current Liabilities Total	63.2M	65.4M	24.4M	12.8M	11.5M	11.0M
Other Current Assets	2.4M	3.3M	2.1M	753K	677.7K	643.8K
Other Stockholder Equity	20.2M	98.3M	144.3M	166.6M	191.6M	201.2M
Total Liab	70.9M	83.5M	40.1M	34.3M	30.8M	57.0M
Property Plant And Equipment Gross	5.6M	5.6M	6.5M	472K	542.8K	515.7K
Total Current Assets	20.1M	36.7M	23.5M	6.3M	7.3M	6.9M
Non Current Liabilities Other	62.8M	56.9M	18.1M	11.3M	10.2M	9.7M
Net Working Capital	12.4M	18.6M	7.8M	(15.1M)	(17.4M)	(16.5M)
Common Stock	94K	487K	983K	16K	18.4K	19.3K
Property Plant Equipment	5.6M	5.1M	5.0M	704K	633.6K	601.9K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
CRM	Salesforce
MSFT	Microsoft

When determining whether Baudax BioInc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Baudax BioInc's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Baudax Bioinc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Baudax Bioinc Stock:

How To Invest In Baudax

Details

Is Baudax Stock a good investment?

Details

What is Baudax BioInc's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.

You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.

Complementary Tools for Baudax Stock analysis

When running Baudax BioInc's price analysis, check to measure Baudax BioInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Baudax BioInc is operating at the current time. Most of Baudax BioInc's value examination focuses on studying past and present price action to predict the probability of Baudax BioInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Baudax BioInc's price. Additionally, you may evaluate how the addition of Baudax BioInc to your portfolios can decrease your overall portfolio volatility.

	Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
	Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
	Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets
	Global Correlations Find global opportunities by holding instruments from different markets
	Commodity Directory Find actively traded commodities issued by global exchanges

Is Baudax BioInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Baudax BioInc. If investors know Baudax will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Baudax BioInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(94.13)

Revenue Per Share

0.318

Quarterly Revenue Growth

(0.23)

Return On Assets

(1.15)

Return On Equity

(47.04)

The market value of Baudax BioInc is measured differently than its book value, which is the value of Baudax that is recorded on the company's balance sheet. Investors also form their own opinion of Baudax BioInc's value that differs from its market value or its book value, called intrinsic value, which is Baudax BioInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Baudax BioInc's market value can be influenced by many factors that don't directly affect Baudax BioInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Baudax BioInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Baudax BioInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Baudax BioInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Baudax Common Stock Shares Outstanding vs Accounts Payable Analysis

Common Stock Shares Outstanding vs Accounts Payable

Common Stock Shares Outstanding vs Accounts Payable Correlation Analysis

Correlation Coefficient

Common Stock Shares Outstanding

Accounts Payable

Baudax BioInc fundamental ratios Correlations

Baudax BioInc Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Baudax BioInc fundamental ratios Accounts

Also Currently Popular

Complementary Tools for Baudax Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Non Current Liabilities Other	+ 1.0	Other Liab
Property Plant Equipment	+ 1.0	Property Plant And Equipment Net
Total Current Liabilities	+ 0.99	Other Current Liab
Non Current Liabilities Total	+ 0.99	Other Liab
Non Current Liabilities Other	+ 0.99	Non Current Liabilities Total
Property Plant Equipment	+ 0.99	Property Plant And Equipment Gross

Short Long Term Debt Total	- 0.99	Non Currrent Assets Other
Common Stock Shares Outstanding	- 0.99	Non Current Assets Total
Net Debt	- 0.97	Other Current Assets
Intangible Assets	- 0.96	Other Stockholder Equity
Current Deferred Revenue	- 0.95	Intangible Assets
Other Stockholder Equity	- 0.95	Non Currrent Assets Other